263 related articles for article (PubMed ID: 22548951)
1. Contribution of the dawn phenomenon to the fasting and postbreakfast hyperglycemia in type 1 diabetes treated with once-nightly insulin glargine.
King AB; Clark D; Wolfe GS
Endocr Pract; 2012; 18(4):558-62. PubMed ID: 22548951
[TBL] [Abstract][Full Text] [Related]
2. How much do I give? Dose estimation formulas for once-nightly insulin glargine and premeal insulin lispro in type 1 diabetes mellitus.
King AB; Clark D; Wolfe GS
Endocr Pract; 2012; 18(3):382-6. PubMed ID: 22440988
[TBL] [Abstract][Full Text] [Related]
3. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
[TBL] [Abstract][Full Text] [Related]
4. Comparison of morning basal + 1 bolus insulin therapy (insulin glulisine + insulin glargine 300 U/mL vs insulin lispro + insulin glargine biosimilar) using continuous glucose monitoring: A randomized crossover study.
Takeishi S; Tsuboi H; Takekoshi S
J Diabetes Investig; 2018 Jan; 9(1):91-99. PubMed ID: 28371461
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro).
Rabasa-Lhoret R; Bourque J; Ducros F; Chiasson JL
Diabetes Care; 2001 Apr; 24(4):625-30. PubMed ID: 11315820
[TBL] [Abstract][Full Text] [Related]
6. A randomized clinical trial comparing breakfast and bedtime administration of insulin glargine in children and adolescents with type 1 diabetes.
Şimşek DG; Yıldız B; Asar G; Darcan S
J Clin Res Pediatr Endocrinol; 2008; 1(1):15-20. PubMed ID: 21318060
[TBL] [Abstract][Full Text] [Related]
7. Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.
Rassam AG; Zeise TM; Burge MR; Schade DS
Diabetes Care; 1999 Jan; 22(1):133-6. PubMed ID: 10333914
[TBL] [Abstract][Full Text] [Related]
8. Effects on post-prandial glucose and AGE precursors from two initial insulin strategies in patients with type 2 diabetes uncontrolled by oral agents.
Sakharova OV; Lleva RR; Dziura JD; Spollett GR; Howell SK; Beisswenger PJ; Inzucchi SE
J Diabetes Complications; 2012; 26(4):333-8. PubMed ID: 22541894
[TBL] [Abstract][Full Text] [Related]
9. Nocturnal blood glucose control in type I diabetes mellitus.
Bolli GB; Perriello G; Fanelli CG; De Feo P
Diabetes Care; 1993 Dec; 16 Suppl 3():71-89. PubMed ID: 8299480
[TBL] [Abstract][Full Text] [Related]
10. Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving preprandial insulin aspart or postprandial insulin glulisine.
Ohta A; Arai K; Nishine A; Sada Y; Kato H; Fukuda H; Asai S; Nagai Y; Katabami T; Tanaka Y
Endocr J; 2013; 60(2):173-7. PubMed ID: 23047542
[TBL] [Abstract][Full Text] [Related]
11. Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times.
Ashwell SG; Gebbie J; Home PD
Diabet Med; 2006 Jan; 23(1):46-52. PubMed ID: 16409565
[TBL] [Abstract][Full Text] [Related]
12. Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes.
Derosa G; Franzetti I; Querci F; Romano D; D'Angelo A; Maffioli P
Diabetes Obes Metab; 2015 Jun; 17(6):554-559. PubMed ID: 25694300
[TBL] [Abstract][Full Text] [Related]
13. Semilente-insulin at bedtime is superior to NPH-insulin for the suppression of the dawn-phenomenon in adolescents with type-I-diabetes.
Holl RW; Teller WM; Heinze E
Exp Clin Endocrinol Diabetes; 1996; 104(5):360-4. PubMed ID: 8957270
[TBL] [Abstract][Full Text] [Related]
14. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.
Ahmed AB; Home PD
Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967
[TBL] [Abstract][Full Text] [Related]
15. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
Raskin P; Klaff L; Bergenstal R; Hallé JP; Donley D; Mecca T
Diabetes Care; 2000 Nov; 23(11):1666-71. PubMed ID: 11092290
[TBL] [Abstract][Full Text] [Related]
16. Comparison of glycemic variability in Japanese patients with type 1 diabetes receiving insulin degludec versus insulin glargine using continuous glucose monitoring: A randomized, cross-over, pilot study.
Onda Y; Nishimura R; Ando K; Takahashi H; Tsujino D; Utsunomiya K
Diabetes Res Clin Pract; 2016 Oct; 120():149-55. PubMed ID: 27562434
[TBL] [Abstract][Full Text] [Related]
17. Comparison of appetite responses to high- and low-glycemic index postexercise meals under matched insulinemia and fiber in type 1 diabetes.
Campbell MD; Gonzalez JT; Rumbold PL; Walker M; Shaw JA; Stevenson EJ; West DJ
Am J Clin Nutr; 2015 Mar; 101(3):478-86. PubMed ID: 25733632
[TBL] [Abstract][Full Text] [Related]
18. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.
Ahmed AB; Mallias J; Home PD
Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613
[TBL] [Abstract][Full Text] [Related]
19. Insulin glargine dosing before next-day surgery: comparing three strategies.
Rosenblatt SI; Dukatz T; Jahn R; Ramsdell C; Sakharova A; Henry M; Arndt-Mutz M; Miller V; Rogers K; Balasubramaniam M
J Clin Anesth; 2012 Dec; 24(8):610-7. PubMed ID: 23122972
[TBL] [Abstract][Full Text] [Related]
20. Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8.
Harris C; Forst T; Heise T; Plum-Mörschel L; Watkins E; Zhang Q; Fan L; Garhyan P; Porksen N
Diabetes Technol Ther; 2017 Aug; 19(8):463-470. PubMed ID: 28817342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
